Lv4
750 积分 2022-04-17 加入
IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis
14小时前
待确认
Discovery of MK-5661, a Once-Daily Oral Na V 1.8 Inhibitor for the Treatment of Pain
2天前
已关闭
Exploring SIK2‐CXCL5 interactions in neutrophils: A novel mechanism for modulating IL‐23 and psoriasis progression
17天前
已完结
Comparative analysis of cGAS catalytic mechanisms across species via combined biochemical assays and computational analysis
23天前
已完结
Prodrug Design to Enhance Bioavailability and Systemic Delivery
1个月前
已完结
Prodrug Design to Enhance Bioavailability and Systemic Delivery
1个月前
已关闭
Suzetrigine (a NaV1.8 inhibitor) versus placebo for acute postoperative pain: A systematic review and meta-analysis of randomized controlled trials
1个月前
已完结
Discovery of Novel SIK2/3 Inhibitors for the Potential Treatment of MEF2C+ Acute Myeloid Leukemia (AML)
1个月前
已完结
Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily
1个月前
已完结
Reducing hERG Inhibition in the Design of Potent and Bioavailable Indazole cGAS Inhibitors
2个月前
已完结
皖公网安备34019202002308
